Modern Diagnostic & Research Centre Ltd (544673) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544673 | NSE: | Hospital & Healthcare Services |

Modern Diagnostic Share Price

91.19 -3.80 -4.00%
as on 08-Jan'26 16:59

DeciZen - make an informed investing decision on Modern Diagnostic

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Modern Diagnostic & Research Centre stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
15.99
Market Cap:
143.4 Cr.
52-wk low:
94.5
52-wk high:
100

Is Modern Diagnostic & Research Centre Ltd an attractive stock to invest in?

1. Is Modern Diagnostic & Research Centre Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Modern Diagnostic & Research Centre Ltd is a below average quality company.

2. Is Modern Diagnostic & Research Centre Ltd undervalued or overvalued?

The key valuation ratios of Modern Diagnostic & Research Centre Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Modern Diagnostic & Research Centre Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Modern Diagnostic & Research Centre Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Modern Diagnostic:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Modern Diagnostic & Research Centre Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 8.4%-17%32.4%39%-
Value Creation
Index
-0.4-2.21.31.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 60.256.367.17878
Sales YoY Gr.--6.5%19.3%16.1%-
Adj EPS -1.3-5.35.38.15.9
YoY Gr.-NANA53%-
BVPS (₹) 10.65.410.718.816.4
Adj Net
Profit
-1.4-5.85.999
Cash Flow from Ops. 3.6-0.17.913.7-
Debt/CF from Ops. 5.6-128.82.61.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA9%16.1%
Adj EPS NANANA53%
BVPSNANA21%76.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-12.3-65.86655.233.7
Op. Profit
Mgn %
10-1.816.623.1NAN
Net Profit
Mgn %
-2.4-10.38.711.511.5
Debt to
Equity
1.72.61.71.1-
Working Cap
Days
08584990
Cash Conv.
Cycle
0-11-590

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 33.70%

Debt to equity has declined versus last 3 years average to 1.07

Sales growth has been subdued in last 3 years 8.99%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Modern Diagnostic & Research Centre Ltd.

Standalone Consolidated
TTM EPS (₹) 5.9 -
TTM Sales (₹ Cr.) 78 -
BVPS (₹.) 16.4 -
Reserves (₹ Cr.) 10 -
P/BV 5.78 -
PE 15.99 -
From the Market
52 Week Low / High (₹) 94.53 / 100.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 143
Equity (₹ Cr.) 15.1
Face Value (₹) 10
Industry PE 91

Management X-Ray of Modern Diagnostic:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Modern Diagnostic - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Modern Diagnostic

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales60566778
Operating Expenses 54575660
Manufacturing Costs2334
Material Costs21181819
Employee Cost 13151618
Other Costs 18211919
Operating Profit 6-11118
Operating Profit Margin (%) 10.0%-1.8%16.5%23.0%
Other Income 0021
Interest 2122
Depreciation 4444
Exceptional Items 0000
Profit Before Tax 1-6713
Tax 3-014
Profit After Tax -1-669
PAT Margin (%) -2.4%-10.2%8.6%11.5%
Adjusted EPS (₹)-1.3-5.25.38.2
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1261221
Share Capital 11111
Reserves 1151110
Minority Interest0000
Debt18131818
Long Term Debt136108
Short Term Debt5779
Trade Payables10898
Others Liabilities 9101218
Total Liabilities 49374965

Fixed Assets

Gross Block51536068
Accumulated Depreciation26293337
Net Fixed Assets 24242731
CWIP 1049
Investments 5000
Inventories2235
Trade Receivables981013
Cash Equivalents 5001
Others Assets 3356
Total Assets 49374965

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 4-0814
PBT 1-6713
Adjustment 5566
Changes in Working Capital -31-6-1
Tax Paid 001-4
Cash Flow From Investing Activity -52-11-13
Capex -5-3-11-13
Net Investments -05-0-0
Others 0000
Cash Flow From Financing Activity 5-63-0
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0-74-2
Interest Paid -1-1-2-2
Dividend Paid 0000
Others 6213
Net Cash Flow 3-400

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-12.41-64.9265.455.21
ROCE (%)8.43-16.9832.4239
Asset Turnover Ratio1.241.321.561.37
PAT to CFO Conversion(x)N/AN/A1.331.56
Working Capital Days
Receivable Days55555054
Inventory Days9111318
Payable Days172190173163

Modern Diagnostic & Research Centre Ltd Stock News

Modern Diagnostic & Research Centre Ltd FAQs

The current trading price of Modern Diagnostic on 08-Jan-2026 16:59 is ₹91.19.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Jan-2026 the market cap of Modern Diagnostic stood at ₹143.4.
The latest P/E ratio of Modern Diagnostic as of 07-Jan-2026 is 15.99.
The latest P/B ratio of Modern Diagnostic as of 07-Jan-2026 is 5.78.
The 52-week high of Modern Diagnostic is ₹100.0 and the 52-week low is ₹94.53.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Modern Diagnostic is ₹77.95 ( Cr.) .

About Modern Diagnostic & Research Centre Ltd

Modern Diagnostic & Research Centre was originally incorporated as ‘Modern Diagnostic & Research Centre Private Limited’ as a private limited company, on April 16, 2012. Subsequently, the company was converted from a private limited company to public limited company pursuant to special resolution passed in the Extraordinary General Meeting of the company held on November 16, 2024 and consequently the name of the company was changed to ‘Modern Diagnostic & Research Centre Limited’.

The company is a services provider in diagnostic and related healthcare tests services in India. Through its integrated nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. It provides healthcare tests and services for use in core testing, patients’ diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The company is focused on providing reliable diagnostic and related healthcare tests and value-added services such as home collection of specimens and online access to test reports. It also offers customized test packages to its institutional customers/patients as per their requirement. The company’s patient centric approach is a critical differentiator which results in several individuals and healthcare providers choosing it as their diagnostic healthcare services provider.

It has also implemented a PACS (Picture Archiving and Communication System) for efficient data storage, retrieval, and management of medical images. This advanced system allows the company to securely store diagnostic images such as X-rays, CT scans, MRIs, and ultrasounds in a digital format, eliminating the need for physical film. Additionally, PACS enables seamless remote access to medical images and reports via the internet. This allows radiologists and healthcare professionals to analyze and interpret diagnostic images from any location, improving workflow efficiency and ensuring faster reporting. With this system, patient data remains securely stored while providing quick and convenient access for accurate diagnosis and timely medical decisions.

Business area of the company 

The company is a services provider in diagnostic and related healthcare tests services in India. Through its integrated nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. 

Services of the company

  • Pathology: The company’s comprehensive pathology services cover multiple specialties, including Haematology, Biochemistry, Clinical Pathology, Serology, Immunology, Histopathology, Cytopathology, Microbiology, Molecular Diagnostics, and Genetic Testing. It offers a wide range of diagnostic tests, such as Complete Blood Counts (CBC), Liver and Kidney Function Tests (LFT/KFT), Lipid Profiles, Hormone Analysis, Autoimmune Disease Markers, Cancer Screening, and Infectious Disease Testing. Additionally, its advanced molecular diagnostics capabilities, including PCR, RT-PCR, Next-Generation Sequencing (NGS), and Oncogene Testing, and LC-MS/MS based tests enable early detection of genetic disorders and chronic diseases.
  • Radiology: The company offers a comprehensive range of radiology services, including MRI (1.5T and 3T), CT scans, ultrasound, color Doppler studies, digital X-rays, mammography, and interventional radiology. It also specializes in advanced diagnostic techniques such as digital mammography for breast cancer detection, DEXA scans for osteoporosis screening, and fluoroscopic imaging for gastrointestinal studies. Its interventional radiology services provide minimally invasive, image-guided procedures, including biopsies, drainage, and reducing the need for surgery.

Awards, accreditations and recognition 

  • 2014: Brand Academy - Healthcare Excellence Awards.
  • 2015: Brand Academy - Global Quality Awards.
  • 2018: Times Healthcare Achievers Awards 2018 by BCCL.
  • 2019: Indian Business Excellence Awards 2019 by WBR Corp UK Limited.

History and milestones

  • 2012-13: Incorporation of the company in the name and style of ‘Modern Diagnostic & Research Centre Private Limited’.
  • 2013-14: Acquisition of Business of M/s Modern Diagnostics & Research Centre, Proprietorship Concern through Business Transfer Agreement. Proprietorship Concern was engaged in the business of Diagnostic Centre.
  • 2024-25: Converted into Public Limited Company in the name and style of ‘Modern Diagnostic & Research Centre Limited’.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×